awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33386523-C2BFC53D-528D-478A-B6D8-C6348FBF543F
Q33386523-C2BFC53D-528D-478A-B6D8-C6348FBF543F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33386523-C2BFC53D-528D-478A-B6D8-C6348FBF543F
A phase I study to characterize the safety, tolerability, and pharmacokinetics of topotecan at 4 mg/m2 administered weekly as a 30-minute intravenous infusion in patients with cancer.
P2860
Q33386523-C2BFC53D-528D-478A-B6D8-C6348FBF543F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33386523-C2BFC53D-528D-478A-B6D8-C6348FBF543F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
209335bea5a4981166d282e6aaaa7291fd26aea6
P2860
Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer.